The present invention relates to novel pyrrole-substituted 2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases, compositions containing these compounds as well as their use in the prevention and treatment of protein kinase related cellular disorders such as cancer.